Suspected de novo Hepatitis B in a Patient Receiving Anti-Tumor Necrosis Factor Alpha Therapy for the Treatment of Crohn's Disease

Suspected de novo Hepatitis B in a Patient Receiving Anti-Tumor Necrosis Factor Alpha Therapy for the Treatment of Crohn's Disease

We report a 45-year-old female patient who developed acute hepatic disorder during anti-tumor necrosis factor α therapy for the treatment of Crohn's disease (CD). She was diagnosed as colonic CD and placed on infliximab (IFX). She was negative for hepatitis B surface antigen at the initiation o...

Full description

Bibliographic Details
Main Authors: Tetsuya Ishida, Hideyasu Nagamatsu, Tetsuya Ueo, Ryoichi Narita, Ken Takahashi, Masaki Urabe, Yuka Yanai, Kazumi Togo
Format: Article
Language:English
Published: Karger Publishers 2014-01-01
Series:Case Reports in Gastroenterology
Subjects:
Crohn’s disease
De novo hepatitis B
Anti-tumor necrosis factor α therapy
Online Access:http://www.karger.com/Article/FullText/358554

Internet

http://www.karger.com/Article/FullText/358554

Similar Items